stock.name

TG Therapeutics Inc

TGTX

Market Cap$2.15B
Close$

Compare TG Therapeutics

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
TG Therapeutics IncTG Therapeutics Inc164.60%8%13.70.6
marketMarket Avg58.91.29%29%-1
HealthcareHealthcare Avg66.31.31%15%-0.9
$16.18

Current Fair Value

18.5% upside

Undervalued by 18.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.15 Billion
Enterprise Value$2.03 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.09
Beta0.0
Outstanding Shares154,542,945
Avg 30 Day Volume2,689,354

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio164.58
PEG-223.81
Price to Sales13.66
Price to Book Ratio13.66
Enterprise Value to Revenue8.7
Enterprise Value to EBIT98.5
Enterprise Value to Net Income155
Total Debt to Enterprise0.05
Debt to Equity0.62

Revenue Sources

No data

ESG Score

No data

About TG Therapeutics Inc

CEO: Michael Weiss